Journal of Peking University(Health Sciences) >
Relationship between lipid metabolism molecules in plasma and carotid atheroscle-rotic plaques, traditional cardiovascular risk factors, and dietary factors
Received date: 2021-06-11
Online published: 2024-07-23
Supported by
the National Natural Science Foundation of China(30872168);the National Natural Science Foundation of China(81473044)
Objective: To explore the relationship between lipid metabolism molecules in plasma and carotid atherosclerotic plaques, traditional cardiovascular risk factors and possible dietary related factors. Methods: Firstly, among 1 312 community people from those who participated in a 10-year follow-up study of subclinical atherosclerosis cohort in Shijingshan District, Beijing, 85 individuals with 2 or more carotid soft plaques or mixed plaques and 89 healthy individuals without plaques were selected according to the inclusive and the exclusive criteria (< 70 years, not having clinical cardiovascular disease and other diseases, etc.). Secondly, 10 cases and 10 controls were randomly selected in the above 85 and 89 individuals respectively. Carotid plaques were detected using GE Vivid i Ultrasound Machine with 8L detector. Lipid metabolism molecules were detected by high performance liquid chromatography-mass spectrometry. The detection indexes included 113 lipid metabolism molecules. Traditional cardiovascular risk factors were collected by unified standard questionnaires, and dietary related factors were collected by main dietary frequency and weight scale. The difference of lipid metabolism molecules between the case group and the control group was analyzed by Wilcoxin rank test. In the control group, the Spearman correlation method was used to analyze the correlation between statistically significant lipid metabolism molecules and traditional cardiovascular risk factors and dietary factors. Results: Among the 113 lipid metabolism molecules, 53 lipid metabolism molecules were detected. C24:0 sphingomyelin (SM), C22:0/ C24:0 ceramide molecules, C18:0 phosphoethanolamine (PE) molecules, and C18:0/C18:2 (Cis) phosphatidylcholine (PC) were significantly higher in the carotid atherosclerotic plaque group than in the control group. The correlation analysis showed that C24:0 SM was significantly positively correlated with low density lipoprotein cholesterol (LDL-C, r=0.636, P < 0.05), C18:2 (Cis) PC (DLPC) was significantly positively correlated with systolic pressure (r=0.733, P < 0.05), C18:0 PE was significantly positively correlated with high sensitivity C-response protein (r=0.782, P < 0.01), C22:0, C24:0 ceramide and C18:0 PE were negatively correlated with vegetable intake (r=-0.679, P < 0.05;r=-0.711, P < 0.05;r=-0.808, P < 0.01), C24:0 ceramide was also negatively correlated with beans food intake (r=-0.736, P < 0.05) in the control group. Conclusions: The increase of plasma C24:0 SM, C22:0, C24:0 ceramide, C18:0 PE, C18:2 (Cis) PC (DLPC), C18:0 PC (DSPC) may be new risk factors for human atherosclerotic plaques. These molecules may be related to blood lipid, blood pressure or inflammatory level and the intake of vegetables and soy products, but the nature of the association needs to be verified in a larger sample population.
Jing HE , Zhongze FANG , Ying YANG , Jing LIU , Wenyao MA , Yong HUO , Wei GAO , Yangfeng WU , Gaoqiang XIE . Relationship between lipid metabolism molecules in plasma and carotid atheroscle-rotic plaques, traditional cardiovascular risk factors, and dietary factors[J]. Journal of Peking University(Health Sciences), 2024 , 56(4) : 722 -728 . DOI: 10.19723/j.issn.1671-167X.2024.04.028
| 1 | Alizargar J , Bai CH . Factors associated with carotid Intima media thickness and carotid plaque score in community-dwelling and non-diabetic individuals[J]. BMC Cardiovasc Disord, 2018, 18 (1): 21. |
| 2 | Gon?alves I , Edsfeldt A , Colhoun HM , et al. Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes[J]. BMC Cardiovasc Disord, 2016, 16 (1): 171. |
| 3 | Lou Y , Li B , Su L , et al. Association between body mass index and presence of carotid plaque among low-income adults aged 45 years and older: A population-based cross-sectional study in rural China[J]. Oncotarget, 2017, 8 (46): 81261- 81272. |
| 4 | Yang D , Iyer S , Gardener H , et al. Cigarette smoking and carotid plaque echodensity in the Northern Manhattan study[J]. Cerebrovasc Dis, 2015, 40 (3/4): 136- 143. |
| 5 | Arnold N , Koenig W . Atherosclerosis as an inflammatory disease-pathophysiology, clinical relevance and therapeutic implications[J]. Dtsch Med Wochenschr, 2019, 144 (5): 315- 321. |
| 6 | 谢高强, 于晖, 陈敬洲, 等. 基因变异及心血管危险因素与单核细胞分泌白细胞介素6和10的关系[J]. 北京大学学报(医学版), 2014, 46 (4): 589- 595. |
| 7 | Xie G , Myint PK , Zaman MJ , et al. Relationship of serum interleukin-10 and its genetic variations with ischemic stroke in a Chinese general population[J]. PLoS One, 2013, 8 (9): e74126. |
| 8 | Xie G , Myint PK , Zhao L , et al. Relationship between-592A/C polymorphism of interleukin-10 (IL-10) gene and risk of early carotid atherosclerosis[J]. Int J Cardiol, 2010, 143 (1): 102- 104. |
| 9 | Paapstel K , Kals J , Eha J , et al. Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis[J]. Nutr Metab Cardiovasc Dis, 2018, 28 (1): 44- 52. |
| 10 | Pechlaner R , Kiechl S , Mayr M . Potential and caveats of lipidomics for cardiovascular disease[J]. Circulation, 2016, 134 (21): 1651- 1654. |
| 11 | 罗杰斯, 谢高强, 于洋, 等. 中老年人群颈动脉内中膜厚度分布特征及相关因素分析[J]. 中国循环杂志, 2013, 28 (4): 278- 281. |
| 12 | Pavoine C , Pecker F . Sphingomyelinases: Their regulation and roles in cardiovascular pathophysiology[J]. Cardiovasc Res, 2009, 82 (2): 175- 183. |
| 13 | Kasumov T , Li L , Li M , et al. Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis[J]. PLoS One, 2015, 10 (5): e0126910. |
| 14 | Colombaioni L , Garcia-Gil M . Sphingolipid metabolites in neural signalling and function[J]. Brain Res Brain Res Rev, 2004, 46 (3): 328- 355. |
| 15 | Kolak M , Westerbacka J , Velagapudi VR , et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity[J]. Diabetes, 2007, 56 (8): 1960- 1968. |
| 16 | Zhao W , Wang X , Deik AA , et al. Elevated plasma ceramides are associated with antiretroviral therapy use and progression of carotid artery atherosclerosis in HIV infection[J]. Circulation, 2019, 139 (17): 2003- 2011. |
| 17 | Yin W , Li F , Tan X , et al. Plasma ceramides and cardiovascular events in hypertensive patients at high cardiovascular risk[J]. Am J hypertens, 2020, 34 (11): 1209- 1216. |
| 18 | Jiang XC , Liu J . Sphingolipid metabolism and atherosclerosis[J]. Handb Exp Pharmacol, 2013, (216): 133- 146. |
| 19 | van der Veen JN , Kennelly JP , Wan S , et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease[J]. Biochim Biophys Acta Biomembr, 2017, 1859 (9 Pt B): 1558- 1572. |
| 20 | Vettraino C , Peracchi A , Donini S , et al. Structural characterization of human O-phosphoethanolamine phospho-lyase[J]. Acta Crystallogr F Struct Biol Commun, 2020, 76 (Pt 4): 160- 167. |
| 21 | Singh SK , Suresh MV , Prayther DC , et al. C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells[J]. J Immunol, 2008, 180 (6): 4316- 4322. |
| 22 | Floegel A , Kühn T , Sookthai D , et al. Serum metabolites and risk of myocardial infarction and ischemic stroke: A targeted metabolomic approach in two German prospective cohorts[J]. Eur J Epidemiol, 2018, 33 (1): 55- 66. |
| 23 | Park J , Jung TW , Chung YH , et al. 1, 2-Dilinoleoyl-Sn-glycero-3-phosphocholine increases insulin sensitivity in palmitate-treated myotubes and induces lipolysis in adipocytes[J]. Biochem Biophys Res Commun, 2020, 533 (1): 162- 167. |
| 24 | Yang L , Wang L , Deng Y , et al. Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy[J]. Lipids Health Dis, 2020, 19 (1): 89. |
| 25 | Hilvo M , Simolin H , Metso J , et al. PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions[J]. Atherosclerosis, 2018, 269, 159- 165. |
/
| 〈 |
|
〉 |